Regenesis Biomedical Inc.
FDA-cleared medical device: $20+ million run rate and cash positive; re-investing in sales, operations and clinical; and expanding payers
Regenesis is a private medical technology company focused on developing and marketing tissue regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Therapy System. Customers include health care facilities and providers that serve patients treated in hospitals, long-term acute care, skilled nursing facilities, rehabilitation centers, and outpatient clinics as well as by patients in their homes.